We have performed an integral and longitudinal study of the immunological responses triggered by the booster mRNA-1273 vaccination
We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus.
The Coronavirus Disease of 2019 (COVID-19) pandemic caused by SARS-CoV-2 led the Spanish government to impose a national lockdown in an attempt to control the spread of the infection.
Vaccines against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are urgently needed.